We have recently identified a tumor suppressor gene TSLC1 on chromosome 11q23.2 by functional complementation of a human lung cancer cell line, A549, through suppression of tumorigenicity in nude mice (1). Furthermore, we have demonstrated the two-hit inactivation of TSLC1 in primary non-small cell lung cancer, hepatocellular carcinoma, and pancreatic cancer, implying its involvement in various human cancers (1). TSLC1 encodes a member of the immunoglobulin superfamily proteins comprising three Ig-like C2-type domains, a single hydrophobic membrane-spanning ␣-helix, and a cytoplasmic domain containing a putative signaling motif (1). From the significant homology of its extracellular domain with those of NCAM1 and NCAM2, 1 we have inferred that TSLC1 is capable of mediating cell-cell interaction.
We have recently identified a tumor suppressor gene TSLC1 on chromosome 11q23.2 by functional complementation of a human lung cancer cell line, A549, through suppression of tumorigenicity in nude mice (1) . Furthermore, we have demonstrated the two-hit inactivation of TSLC1 in primary non-small cell lung cancer, hepatocellular carcinoma, and pancreatic cancer, implying its involvement in various human cancers (1) . TSLC1 encodes a member of the immunoglobulin superfamily proteins comprising three Ig-like C2-type domains, a single hydrophobic membrane-spanning ␣-helix, and a cytoplasmic domain containing a putative signaling motif (1) . From the significant homology of its extracellular domain with those of NCAM1 and NCAM2, 1 we have inferred that TSLC1 is capable of mediating cell-cell interaction.
Cell adhesion molecules generally fall into four major classes: the cadherins, the integrins, the selectins, and the Ig superfamily. Among them, Ig superfamily cell adhesion molecules (IgCAMs) are the largest, numbering well over 100 members in vertebrates (2) . These well-characterized molecules include NCAMs (3), L1 family CAMs (4), and nectins (5) (6) (7) (8) (10) . In combination with these interactions, IgCAMs promote a variety of cell-cell associations through cis interaction within the plane of the membranes and/or trans interaction across the membranes (2, 11) . For instance, the heterophilic cis interaction between L1 and NCAM appears to enhance the homophilic trans-binding activity of L1 (12, 13) . Nectins form cis-homodimers that undergo homophilic and heterophilic trans interactions with each other to mediate cell-cell adhesion (6, 11) .
In this study, the biochemical properties and subcellular localization of TSLC1 were investigated in the cells expressing TSLC1 tagged with GFP or endogenous TSLC1. We report the physiological properties of TSLC1 along with several lines of evidence that TSLC1 is a single transmembrane glycoprotein involved in cell-cell aggregation through homophilic trans interaction.
EXPERIMENTAL PROCEDURES
Cells-Human embryonic kidney (HEK) 293 (JCRB9068) and MDCK cells (JCRB9029) were obtained from the Human Science Research Resources Bank (Osaka, Japan). HEK293 cells were maintained in Dulbecco's modified Eagle's medium (Sigma Chemical Co., St. Louis, MO) supplemented with 10% fetal calf serum (FCS), whereas MDCK cells were grown in Eagle's minimum essential medium (Sigma Chemical) supplemented with 0.1 mM nonessential amino acids (Invitrogen, Carlsbad, CA), 1.0 mM sodium pyruvate (Invitrogen), and 10% FCS. Human colorectal carcinoma Caco-2 (HTB-37) cells were purchased from ATCC (Rockville, MD) and maintained in Eagle's minimum essential medium supplemented with 0.1 mM nonessential amino acids, 1.0 mM sodium pyruvate, and 20% FCS. All media used in this study contained 100 units/ml penicillin and 100 g/ml streptomycin (Invitrogen).
Antibodies-For immunoprecipitation and immunoblot analysis of green fluorescent protein (GFP), monoclonal and polyclonal antibodies against GFP were purchased from MBL (Nagoya, Japan). Rabbit polyclonal antibodies against HA (sc-7392) and ZO-1 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA) and Zymed Laboratories Inc. (South San Francisco, CA), respectively. A rabbit polyclonal antibody against TSLC1 (CC2) was raised against 18 synthetic polypeptides of the C terminus of TSLC coupled with keyhole limpet hemocyanin and purified with an affinity column (Asahi Technoglass, Japan). Secondary antibodies for immunoblot analysis were from Amersham Biosciences (Buckinghamshire, England). Fluorescein isothiocyanate-or rhodamine-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratory, West Grove, PA) was used as a secondary antibody for immunofluorescence staining.
Construction of Expression Vectors-Construction of pTSLC1-GFP was described previously (1) . For the construction of pTSLC1-HA, an HA epitope tag (YPYDVPDYA) was introduced at the C terminus of TSLC1, which was cloned into the expression vector pcDNA3 (pcTSLC1) in our previous study (1) .
Transfection-To prepare MDCK cells stably expressing TSLC1-GFP (MDCK/TSLC1-GFP), MDCK cells were transfected with pTSLC1-GFP using LipofectAMINE Plus reagent (Invitrogen) according to the manufacturer's protocol. Stable clones were selected in the media containing 500 g/ml Geneticin (G418) (Invitrogen). Stably transfected clones were maintained in the presence of 300 g/ml G418. HEK293 cells were transiently transfected with pTSLC1-GFP and/or pTSLC1-HA as described above.
Protein Analysis-Cell lysates were prepared using a lysis buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 20 mM EDTA, and a protease inhibitor mixture (Calbiochem, San Diego, CA). The cell extract was centrifuged at 12,000 rpm for 1 min at 4°C to remove insoluble material, and the supernatant was collected. Protein concentration of each sample was determined by the method of Bradford using a protein assay dye reagent (Bio-Rad, Hercules, CA). For immunoprecipitation, cell lysates were incubated with an appropriate primary antibody overnight at 4°C and then added with protein ASepharose (Amersham Biosciences). Immunoprecipitates were rinsed four times with the lysis buffer, suspended in a sample buffer (Invitrogen) containing 50 mM dithiothreitol, and incubated at 70°C for 10 min. The samples were fractionated in 4 -12% gradient SDS-PAGE, transferred to a polyvinylidene difluoride membrane (Millipore, Bedford, MA), and reacted with a mouse monoclonal antibody against GFP. The binding of the primary antibody was detected with Lumi-Light PLUS Western blotting Substrate (Roche Diagnostics, Basel, Switzerland) using a peroxidase-conjugated secondary antibody.
N-Linked Glycosylation Analysis-For inhibiting N-linked glycosylation, when MDCK cells reached 70% confluence, the medium was replaced with a fresh medium containing 5 g/ml tunicamycin (SigmaAldrich). Two days later, cell lysates were prepared and incubated with anti-GFP polyclonal antibody as described above. For enzymatic digestion of N-linked oligosaccharides, immunoprecipitated proteins were washed three times with a lysis buffer and eluted by boiling for 5 min in 150 mM sodium citrate (pH 5.5), 0.6% SDS, and 1.5% ␤-mercaptoethanol. The eluted samples were treated with 1.5 unit of N-glycosidase F (Roche Diagnostics) and incubated overnight at 37°C according to the manufacturer's instruction. The samples were then resolved by SDS-PAGE, and immunoblot detection of GFP-tagged proteins was carried out as described above.
Chemical Cross-linking with BS 3 -A monolayer of nonpolarized MDCK/TSLC1-GFP cells was rinsed twice with PBS and incubated in PBS containing 3 mM bis(sulfosuccinimidyl) suberate (BS 3 , Pierce, Rockford, IL) at room temperature with constant agitation for 20 min. The reaction was quenched with the addition of 20 mM Tris-HCl, pH 7.5. Protein samples were then prepared by lysing the cross-linked cells in a lysis buffer containing 10 mM iodoacetamide. For chemical crosslinking of dissociated cells, 293 cells were rinsed with PBS, trypsinized, and dispersed by gentle pipetting. The cells were resuspended in PBS at 5 ϫ 10 5 cells/ml, transferred to 15-ml polypropylene tubes (Corning Inc., Corning, NY), and incubated in the presence or absence of 3 mM BS 3 at room temperature with constant agitation for 20 min. The reaction was stopped as described above. To assure a single-cell suspension, the cells were subjected to phase-contrast microscopy before and after the chemical cross-linking reaction. The cells were then spun down and added to a lysis buffer containing 10 mM iodoacetamide (Sigma-Aldrich) to obtain protein samples.
Cell Aggregation Assay-A cell aggregation assay was performed as described previously (14) . To improve the detachment efficiency, a monolayer of MDCK cells or MDCK/TSLC1-GFP cells was trypsinized 1 day prior to the experiment, split into two 100-mm plates, and cultured overnight. Subconfluent layers were rinsed twice with Ca 2ϩ -and Mg 2ϩ -free PBS, detached by incubation in 0.2% trypsin/1 mM EDTA at 37°C for 5 min, and dispersed by gentle pipetting. After washing in Ca 2ϩ -and Mg 2ϩ -free Hanks' balanced salt solution (HBSS), the cells were resuspended in normal HBSS containing Ca 2ϩ and Mg 2ϩ (Invitrogen), Ca 2ϩ -and Mg 2ϩ -free HBSS (Invitrogen), or Ca 2ϩ -and Mg 2ϩ -free HBSS containing 5 mM EDTA (5 ϫ 10 5 cell/ml). The cell suspension (1 ml/well) was reseeded in 12-well plates precoated with bovine serum albumin fraction V (Sigma Chemical Co.) and rotated on a gyratory shaker at 37°C for 20, 40, or 60 min. Aggregation was stopped with the addition of 2% glutaraldehyde. The extent of aggregation of cells was represented by the ratio of the total particle number at time t of incubation (N t ) to the initial particle number (N 0 ).
Immunostaining and Confocal Microscopy-Cells were seeded on BIOCOAT collagen I-coated eight-well culture slides (Becton Dickinson Labware, Bedford, MA) a couple of days before fixation. For polarity experiments, MDCK/TSLC1-GFP or Caco-2 cells were seeded at a density of 1 ϫ 10 5 cells per 24-mm Transwell-COL collagen-coated filter insert (Costar, Cambridge, MA) and allowed to grow to confluence for 3-4 days. The cells were washed twice in PBS (pH 7.2) and fixed with 4% paraformaldehyde in PBS for 20 min at room temperature. For indirect fluorescent microscopy of HEK 293 or Caco-2, cells were seeded and fixed as described above. Fixed cells were then permeabilized with 0.1% Triton in PBS for 5 min, washed three times with PBS, blocked for 30 min with 5% normal donkey serum (Chemicon International, Inc., Temecula, CA) in PBS, and stained with the indicated primary antibodies diluted in 1% normal donkey serum overnight at room temperature. After washing three times with PBS, fluorophore-conjugated secondary antibodies were applied for 1 h at room temperature and washed with PBS. The slides were mounted with a Vectashield antifade reagent (Vector Laboratories, Burlingame, CA), covered with glass coverslips, and examined with a Zeiss LSM510 or Bio-Rad Radiance 2000 laser confocal scanning system equipped with a 488/514-nm argon and a 543-nm helium-neon laser. The X-Z vertical sections were generated with a 0.2-m motor step. Each image represents a single averaged (16-line scan) image.
RESULTS

N-Linked Glycosylation of TSLC1-
In an attempt to elucidate the physiological function of TSLC1, an expression vector for TSLC1 tagged with GFP at its C terminus (pTSLC1-GFP) (1) was introduced into MDCK cells, and stable transfectants (MDCK/TSLC1-GFP cells) were obtained. 200 g of protein samples prepared from the cells was immunoprecipitated with anti-GFP polyclonal antibody followed by immunoblot analysis with anti-GFP monoclonal antibody, generating a single band at 100 kDa (Fig. 1B, lane 2) . By subtracting the molecular mass of GFP, 27 kDa, the size of TSLC1 was estimated at ϳ75 kDa. The sequence analysis of TSLC1 predicted that its extracellular domain bears six NX(S/T) motifs for N-linked glycosylation (Fig. 1A) . We, therefore, enzymatically digested the TSLC1-GFP protein with N-glycosidase F to release putative N-linked oligosaccharides. Approximately one half of the 100-kDa species was replaced with an 80-kDa species, confirming that TSLC1 was indeed glycosylated (Fig. 1B, lane 3) even though a 100-kDa species remained detectable even after the treatment, presumably due to incomplete digestion with N-glycosidase F. Consistent with this result, treating MDCK/TSLC1-GFP cells with tunicamycin for 48 h, an antibiotic that inhibits N-linked glycosylation, also gave rise to a band at 80 kDa (Fig. 1B, lanes  4 and 5) . These results indicate that the size of TSLC1 in a deglycosylated form is ϳ50 kDa.
Dimerization of TSLC1 on Plasma Membrane-Previous studies have shown that the majority of IgCAMs function through homophilic and/or heterophilic interaction (2, 10). We therefore investigated pre-existing forms of TSLC1 on the cell membrane by treating the monolayer of nonpolarized MDCK/ TSLC1-GFP cells with BS 3 , a noncleavable membrane-impermeable cross-linker. Protein samples were prepared in the presence of iodoacetamide to prevent the formation of nonspecific disulfide linkages. Immunoprecipitation of the cross-linker-treated samples followed by immunoblot analysis yielded an additional signal with a molecular mass of ϳ200 kDa ( Fig. 2A,  upper band) , which seemed to represent the dimerized form of TSLC1-GFP present on the cell surface. We thus examined whether TSLC1 forms homodimers by transiently coexpressing TSLC1-GFP and TSLC1-HA in human embryonic kidney 293 cells. The protein samples prepared from these cells were immunoprecipitated with anti-GFP polyclonal antibody and immunoblotted with a monoclonal anti-HA antibody. The result revealed coimmunoprecipitation of TSLC1-HA with TSLC1-GFP (Fig. 2B, right panel) , indicating that TSLC1molecules were dimerized through homophilic interaction. These results led us to analyze the pre-existing forms of endogenous TSLC1 on the cell membrane. Several cell lines were tested for their expression of endogenous TSLC1 by Western blot analysis using anti-TSLC1 polyclonal antibody (CC2), which recognizes the C terminus of TSLC1, and it was found that HEK293 cells expressed a considerable amount of endogenous TSLC1 (data not shown). A single-cell suspension of HEK293 cells was incubated in the presence or absence of a chemical cross-linker BS 3 followed by Western blot analysis with a CC2 antibody.
Without a chemical cross-linker, a single band was detected at 75 kDa (Fig. 2C) , which was compatible with the molecular size of TSLC1 estimated from the size of TSLC1-GFP (ϳ100 kDa) described above. By contrast, with 3 mM BS 3 , an immunoreactive signal was detected predominantly at 150 kDa on the blot (Fig. 2C) , indicating that TSLC1 substantially exists as homodimers on the cell surface. Since chemical cross-linking was performed after dissociation of the cells, the homodimers of TSLC1 observed were most likely the consequence of cis interaction within the plane of the membrane of individual cells. In this regard, treating the monolayer of nonpolarized MDCK/ TSLC1-GFP cells with BS 3 also showed a signal corresponding to monomeric TSLC1-GFP ( Fig. 2A) , which could be an artifact caused by overexpression of TSLC1-GFP.
Subcellular Localization of TSLC1 in MDCK Cells-We explored subcellular distribution of TSLC1 in MDCK/TSLC1- GFP cells at a range of cell densities by confocal laser scanning microscopy. When cells were well spread, TSLC1 molecules were distributed to punctate structures in the cytoplasm and at the tip of cell surface protrusions that were about to make contact with neighboring cell surfaces (Fig. 3, A1-A2 ). It is intriguing that, at the initial stage of cell-cell attachment, TSLC1 was concentrated to zipper-like structures at the cellcell boundaries, where filopodia are thought to penetrate and embed into opposing cells (Fig. 3, B1-B2 ). Once cells became confluent, TSLC1 protein was localized to all along cell membranes (Fig. 3, C1-C2 ). We next viewed subcellular localization of endogenous TSLC1 in HEK 293 cells. Immunostaining for endogenous TSLC1 with a CC2 antibody exhibited similar patterns to those of TSLC1-GFP exogenously introduced into MDCK cells at either low (Fig. 4, A1-A3 ) or high (Fig. 4, B1-B3 ) cell density.
The distribution of TSLC1 was further examined in polarized MDCK/TSLC1-GFP cells by confocal laser scanning microscopy. The cells were also stained for ZO-1, a protein restricted to tight junction (15) , to compare its localization with that of TSLC1-GFP. In the X-Y confocal sections, TSLC1-GFP was distributed to honeycomb-like structures at cell-cell boundaries as well as ZO-1 (Fig. 5A, upper panels) . In the X-Z vertical cross-section, ZO-1 staining revealed intense dots along the apical cell surface, where the apical and lateral cell membranes meet (Fig. 5A, lower panel in red) . In contrast, TSLC1-GFP was detected predominantly on the lateral surface of the cells (Fig.  5A, lower panel in green) showing distinctive localization from that of ZO-1. Distribution of endogenous TSLC1 was also examined in polarized Caco-2 cells found to express endogenous TSLC1 (data not shown). Immunostaining for endogenous TSLC1 and ZO-1 in the polarized Caco-2 cells (Fig. 5B) exhibited very similar patterns to those of TSLC1-GFP in MDCK cells showing the lateral-specific localization (Fig. 5A) . These results suggest that TSLC1 molecules achieve lateral localization through its trans interaction across the membranes as often seen in other adhesion molecules. It is also noteworthy that the subcellular localization seen in TSLC1-GFP/MDCK cells was compatible with that of endogenous TSLC1.
TSLC1 Mediates Ca 2ϩ /Mg 2ϩ -independent Cell-Cell Aggregation in MDCK Cells-In the last set of experiments, we employed a well-established cell aggregation assay (14) to further assess trans interaction of TSLC1. MDCK/TSLC1-GFP or the parental MDCK cells were dissociated, resuspended in HBSS, and incubated at 37°C for various periods of time. The requirement for divalent cations such as Ca 2ϩ and Mg 2ϩ in TSLC1-mediated adhesion activity was also tested in Ca 2ϩ / Mg 2ϩ -free HBSS in the presence or absence of 10 mM EDTA. Although parental MDCK cells showed little aggregation in the time frame of these experiments, MDCK cells expressing TSLC1-GFP significantly aggregated in a time-dependent manner (Fig. 6A) . The degree of aggregation of MDCK/TSLC1-GFP was comparable in either the presence or absence of Ca 2ϩ and Mg 2ϩ (Fig. 6A ), indicating that TSLC1-mediated cell aggregation does not require either of the divalent cations. When incubated in HBSS with the divalent cations, the parental MDCK cells exhibited weak cell-aggregation activity (Fig. 6A) , presumably caused by Ca 2ϩ -dependent cadherin endogenously expressed in MDCK cells. Taken together, these results suggest that TSLC1 mediates intercellular adhesion through homophilic trans interaction in a Ca 2ϩ /Mg 2ϩ -independent manner. DISCUSSION TSLC1 is a unique tumor suppressor gene, because it was identified by its direct activity of tumor suppression in nude mice when introduced in cancer cells. When TSLC1 was introduced into A549 cells lacking endogenous TSLC1, cell growth in vivo was significantly suppressed, whereas the growth rate of the cells in vitro was not affected (1) . Based on this observation, we have assumed that suppression of a malignant phenotype of cancers by TSLC1 is not due to direct arrest of the cell cycle but to some other mechanism, such as the regulation of cell growth through cell-to-cell or cell-to-substrate interaction. In support of this notion, the amino acid sequence analysis of TSLC1 revealed significant homology of the extracellular domain of TSLC1 with those of NCAM1 and NCAM2. We, therefore, have assessed our hypothesis by characterizing TSLC1 and demonstrated that TSLC1 is a member of IgCAMs.
Biochemical analysis has shown that TSLC1 is an N-linked tional modification, has been reported to modulate its function by inhibiting its homophilic interaction with the bulky sugar residues (10).
Analysis of the subcellular localization of TSLC1 with confocal microscopy revealed the characteristic pattern to adhesion molecules. In nonpolarized cells, TSLC1 molecules were accumulated at the cell-cell contact sites. Similar patterns of subcellular localization were reported in other adhesion molecules, including E-cadherin and nectins (5) (6) (7) . In polarized cells, TSLC1 was recruited to the lateral membrane but not to the apical or basal membranes, suggesting the trans interaction of TSLC1 between apposing cells. In favor of this idea, the aggregation assay has demonstrated that TSLC1 mediates cell aggregation through homophilic trans interaction. In addition, we have found that this adhesive activity is independent of diva- HEK293 cells were seeded on culture slides at various cell densities. A few days later, the cells were permeabilized and stained for TSLC1 with a anti-TSLC1 polyclonal antibody (CC2) as described under "Experimental Procedures." Laser scanning confocal microscopy was performed with a filter set suitable for rhodamine detection (panels A1 and B1) and differential interference contrast (DIC) (panels A2 and B2). Bars represent 10 m. Note: At low cell density (panels A1-A3), staining for TSLC1 showed either "zipper-like" structures or completely sealed stable lines at cell-cell boundaries (A1). When confluent, a honeycomb-like distribution of TSLC1 was seen (B1). lent cations, confirming that TSLC1 retains one of the characteristics of IgCAMs. It should be noted that chemical cross-linking of TSLC1-GFP in a monolayer of nonpolarized MDCK/TSLC1-GFP cells showed several additional bands with higher molecular weight on the blot by longer exposure (data not shown), suggesting heterophilic trans/cis interaction of TSLC1 with other proteins that are endogenously expressed in the cells. Alternatively, these may represent a small amount of higher order homooligomers of TSLC1-GFP. Growing evidence indicates that most adhesion molecules transduce signaling by associating with other adhesion molecules and/or receptors for a soluble ligand (4, 16, 17) . Hence, identification of hetero-interacting partners for TSLC1 may lead to finding novel signaling pathways underlying its biological functions.
Accumulating reports indicate that Ig superfamily proteins are multifunctional and participate in the regulation of various cellular activities. In some instances, they play a role in regulating cellular response in the immune system (18, 19) . These examples include sialic acid binding Ig-like lectins (siglecs) expressed in hematopoietic cells, which are reported to downregulate cellular activation of immune system to prevent inappropriate auto-reactivity (18, 19) . Furthermore, many of the Ig superfamily proteins are associated with malignancy. Whereas TSLC1 has been identified as a tumor suppressor, glycophosphatidylinositol-anchored carcinoembryonic antigen, another homophilic Ca 2ϩ -independent adhesion IgCAM, promotes dedifferentiation and is one of the widely used tumor markers in clinical medicine (20, 21) . In this study, we have demonstrated that TSLC1 is involved in cell-cell adhesion. Recent extensive studies on adhesion molecules have revealed that adhesion has profound effects on cells that go far beyond merely gluing them together (2). They play important and diverse roles in many aspects of cell behavior during the normal development, growth, or maintenance of tissues (22) . Altered adhesion properties have been recognized as a feature of cancer cells, and this is true for E-cadherin, another tumor suppressor (23) . Notably, its alterations are often observed in the advanced stages of epithelial cancers (24) . Loss of E-cadherin function, besides disrupting cell-cell adhesion, was suggested to convey signals that actively induce tumor invasion and/or metastasis (2, 23) . It therefore is probable that aberrant TSLC1 contributes to invasion or metastasis to surrounding or distal tissues in a similar manner. Elucidating the molecular mechanisms through which TSLC1 regulates cell-cell interactions may provide appropriate molecular targets for future cancer therapy.
